Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cyclophosphamide small-cell lung carcinoma

Small cell lung carcinoma Multiple combinations that include cyclophosphamide, cisplatin, doxorubicin, etoposide, and vincristine... [Pg.481]

Cyclophosphamide is a component of CMF (cyclophosphamide, methotrexate, 5-fluorouracil) and other drug combinations used in the treatment of breast cancer. Cyclophosphamide in combination may produce complete remissions in some patients with ovarian cancer and oat cell (small cell) lung cancer. Other tumors in which benehcial results have been reported include non-oat cell lung cancers, various sarcomas, neuroblastoma, and carcinomas of the testes, cervix, and bladder. Cyclophosphamide also can be employed as an alternative to azathioprine in suppressing immunological rejection of transplant organs. [Pg.641]

Taylor, S. G., Donavan, M. A., Sponzo, R. W., Cummingham, T. J. and Horton, J. (1975) Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule. Cancer Chemother. Rep., 59, 1127. [Pg.350]

See other pages where Cyclophosphamide small-cell lung carcinoma is mentioned: [Pg.110]    [Pg.400]    [Pg.66]    [Pg.882]    [Pg.186]    [Pg.186]    [Pg.132]    [Pg.188]    [Pg.888]    [Pg.532]    [Pg.42]    [Pg.156]   
See also in sourсe #XX -- [ Pg.200 ]



SEARCH



Carcinoma cells

Cyclophosphamide

Cyclophosphamides

Lung carcinoma

Lung carcinoma cells

Lung small cell

Small-cell lung carcinoma

© 2024 chempedia.info